[Preparation strategies of magnetite/metal-organic framework composites and their application progress in sample pretreatment]. [PDF]
Li YX, Lu MH.
europepmc +1 more source
[An excerpt of the European Association for the Study of the Liver's clinical practice guidelines on liver vascular diseases in 2025]. [PDF]
Luo BH, Han GH.
europepmc +1 more source
[Efficacy of tenofovir monotherapy or lamivudineadefovir dipivoxil combination therapy in treatment of lamivudine-resistant chronic hepatitis B]. [PDF]
Qi JH, Ju JC, Xu L, Zhang NN, Chen B.
europepmc +1 more source
[Research progress on sample pretreatment technology for the analysis of new pollutants in food using composite covalent organic framework materials]. [PDF]
Sun ZY, Yuan GN, Niu YY, Ma JP.
europepmc +1 more source
[Research advances in three-dimensional bioprinted wound dressings]. [PDF]
Shi C, Lei C, He L, Liao D.
europepmc +1 more source
[A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B]. [PDF]
Zhu SS +10 more
europepmc +1 more source
Research progress on the nucleoside/nucleotide-loaded nanomedicines. [PDF]
Zhou Z, Liu H, Ye M.
europepmc +1 more source
[A case of tenofovir amibufenamide rescue treatment in entecavir-resistance combined with renal insufficiency]. [PDF]
Xia GM +5 more
europepmc +1 more source
[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]
Wang ZW +11 more
europepmc +1 more source
[Compare the effect of combined therapy between telbivudine plus adefovir dipivoxil and lamivudine plus adefovir dipivoxil corresponding to renal function in patients with hepatitis B virus infection]. [PDF]
Xu J +6 more
europepmc +1 more source

